Real-World Effectiveness of COVID-19 VaccineClalit Research Institute | February 25, 2021 First peer-reviewed real-world study of COVID-19 vaccine examined 600,000 vaccinated individuals
Landmark Study Details New Human Reference GenomesUniversity of Maryland School of Medicine | February 25, 2021 The study provides new insights into the structure, variation, and mutation of the human genome
People with SARS-CoV-2 Antibodies May Be Protected against ReinfectionNational Cancer Institute, National Institutes of Health | February 24, 2021 The new findings may explain why reinfection with the novel coronavirus appears to be relatively rare
A New Way to Prevent and Treat Endometrial Cancer RecurrenceYale University | February 24, 2021 Researchers demonstrate sex hormones and insulin growth factors are associated with recurrence of endometrial cancer
March 24, 2021Practical Ways to Motivate Lab StaffClinical Lab Manager | February 23, 2021 Join Clinical Lab Manager as we present tips and solutions to keep your staff motivated
New Insights on How Interleukin-33 Contributes to Skin and Pancreatic CancersMassachusetts General Hospital | February 23, 2021 The results suggest that inhibiting IL-33 in cancer-prone cells may help prevent cancers associated with inflammation
New CRISPR-Based Gene Editing Tool Makes Sequential Genome EditsUniversity of Illinois at Chicago | February 23, 2021 With the new gene editing technique, researchers can program sequential genome edits over time
Researchers Develop Test to Measure Effect of Breast Cancer Gene VariantsMayo Clinic | February 22, 2021 The new test can determine the clinical importance of many BRCA2 variants of uncertain significance
Absence of Natural Killer Cell Receptor Associated with Severe COVID-19Medical University of Vienna | February 22, 2021 People with partial or total absence of the natural killer cell receptor are most likely to develop severe COVID-19
Can Cell-Free DNA in Urine Be Used to Detect Cancer?The Translational Genomics Research Institute | February 19, 2021 Study confirms that cell-free DNA in urine can differentiate between healthy individuals and those with cancer
Differences in Antibody Response May Drive COVID-19 OutcomesMassachusetts General Hospital | February 19, 2021 Study identifies the specific types of antibodies that may be driving COVID-19 outcomes in both children and adults
Combined Neoadjuvant Immunotherapy Improves NSCLC OutcomesUniversity of Texas MD Anderson Cancer Center | February 18, 2021 This is the first randomized study to report on the role of combination checkpoint inhibitors for early stage NSCLC
Study Finds Negligible Detection of Coronavirus in Hematology/Oncology SettingsRutgers University | February 18, 2021 Researchers found extremely low detection of SARS-CoV-2 on surfaces across multiple outpatient and inpatient areas
Molecular Imaging Determines Effectiveness of Novel Metastatic Breast Cancer TreatmentSociety of Nuclear Medicine and Molecular Imaging | February 17, 2021 PET imaging using 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy
Immune System Protects Children from Severe COVID-19 Murdoch Children's Research Institute | February 17, 2021 Study finds children with COVID-19 have a more robust innate immune response to the virus compared to adults
Insight about Tumor Microenvironment Could Boost Cancer ImmunotherapyUniversity of Pittsburgh | February 16, 2021 Study shows how chemicals in the tumor microenvironment subvert the immune system, enabling cancer to evade attack
Global, Equitable Distribution of Safe COVID-19 Vaccines Is ImperativeThe Lancet | February 16, 2021 COVID-19 vaccination potential won't be achieved without increased production, affordable pricing, global availability, and successful rollout
SARS-CoV-2 Mutates to Escape Antibody BindingUniversity of Pittsburgh | February 15, 2021 Researchers unearth how SARS-CoV-2 evolves into new variants that can evade antibodies
Genomic Test Helps Estimate Risk of Prostate Cancer Metastasis, DeathJohn Hopkins Medicine | February 15, 2021 The commercially available test can help determine which patients may benefit from hormone therapy
New Drug Leads to 30% Reduced Risk of Death for Bladder Cancer PatientsQueen Mary University of London | February 12, 2021 A new type of drug that targets chemotherapy directly to cancer cells significantly increased patient survival